French Luxury Stock News

As European markets see a rise in optimism due to hopes of a shorter-than-expected Middle East conflict, the pan-European STOXX Europe 600 Index has climbed 3.92%, reflecting positive sentiment across major indices like Germany's DAX and Italy's FTSE MIB. In this environment of fluctuating energy prices and inflation concerns, dividend stocks can offer investors stability through consistent income streams, making them an appealing choice for those looking to navigate uncertain market conditions.

The European market has recently experienced a wave of optimism, with the STOXX Europe 600 Index climbing nearly 4% amid hopes for a shorter-than-expected conflict in the Middle East. As investors navigate these turbulent times, penny stocks—often seen as relics of past trading days—still present relevant opportunities for growth. These smaller or newer companies can offer significant returns when supported by strong financial health and solid fundamentals, making them an intriguing option...

Recent share performance and business profile Pluxee (ENXTPA:PLX) has drawn investor attention after a period of mixed share performance, with a 7 day gain of 5.8% set against weaker returns over the past month and past 3 months. The stock closed at €10.55, implying a market value of about €1.5b. The business continues to focus on employee benefits and engagement services across France, Latin America, Continental Europe and other international markets. For readers tracking fundamentals,...

Dividend proposal and upcoming earnings put STMicroelectronics in focus STMicroelectronics (ENXTPA:STMPA) is drawing attention after proposing a US$0.36 per share cash dividend, to be paid in four US$0.09 quarterly installments, alongside the upcoming first quarter 2026 earnings release and outlook update. See our latest analysis for STMicroelectronics. At a share price of €29.09, STMicroelectronics has seen a 24.08% year to date share price return and a 73.06% total shareholder return over...

What the recent price move says about Exosens Exosens (ENXTPA:EXENS) has caught investor attention after a recent share price move, with the stock closing at €65.20 and short term returns over the past week, month, and past 3 months standing in positive territory. See our latest analysis for Exosens. Beyond the recent jump, Exosens has combined strong short term share price momentum with a very large 1 year total shareholder return of 104.23%, which suggests shifting expectations around its...

Inventiva (ENXTPA:IVA) is back on investors’ radars after completing enrollment in its global Phase III NATiV3 trial for lanifibranor in MASH, while selling odiparcil rights to focus resources and potential future milestone income. See our latest analysis for Inventiva. At a share price of €4.72, the stock has a 90 day share price return of 19.8% and a 1 year total shareholder return of 82.95%, suggesting momentum has been building as investors focus on the NATiV3 progress and portfolio...

Hexaom S.A.'s ( EPA:ALHEX ) solid earnings announcement recently didn't do much to the stock price. Our analysis...

L'Oréal (ENXTPA:OR) has completed a €4b acquisition of Kering Beauté. The deal includes exclusive beauty rights for Creed, Balenciaga, and Bottega Veneta. The company and Kering have formalized a long-term partnership focused on luxury, wellness, and longevity. L'Oréal, a global beauty group with a wide portfolio spanning mass, premium, and luxury brands, is adding more depth to its high end offering with Kering Beauté. For readers tracking the luxury segment, this deal sits at the...

Contract wins in Indonesia set the context Vallourec (ENXTPA:VK) recently reported a series of five contracts in Indonesia for about 36,000 tons of premium pipes and connections, supplying complex offshore oil and gas projects across roughly 140 wells. See our latest analysis for Vallourec. These Indonesia contract wins come as the share price trades at €22.04, with a 15.42% 1 month share price return and a 37.75% year to date share price return, alongside a 61.15% 1 year total shareholder...

Wondering whether LVMH Moët Hennessy - Louis Vuitton Société Européenne is starting to look attractively priced? This article focuses squarely on what you are getting for the price you pay. The stock last closed at €471.05, with a 3.4% return over 7 days, a 6.9% decline over 30 days, and year-to-date and 1-year returns of 26.6% and 9.0% declines, alongside a 39.8% decline over 3 years and a 12.6% decline over 5 years. Recent coverage around LVMH Moët Hennessy - Louis Vuitton Société...

Recent Share Performance and Business Snapshot Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) has seen a mix of short term moves, with a 1 day return of about a 1% decline, contrasting with gains over the past week and the past 3 months. Over the past month the stock shows a return of about a 5% decline, while year to date performance is positive. The current share price of €29.69 sits alongside a market value of about €20.4b. Michelin reports...

Fresh look at Amundi after recent performance shifts Amundi (ENXTPA:AMUN) is back on investor radars after mixed recent returns, with a 1 day decline, a small gain over the past week, and a slight drop over the past month. See our latest analysis for Amundi. With the share price at €74.1, Amundi’s recent setbacks over the past day and month contrast with a positive 90 day share price return of 4.07% and a stronger one year total shareholder return of 25.55%. This suggests earlier momentum has...

Event overview and recent share performance Arkema (ENXTPA:AKE) shares recently closed at €58.10 after a mixed stretch, with a small 1 day decline, a broadly flat week, and positive moves over the past month and past 3 months. Over longer horizons the picture is different. The stock has shown a 3% decline over the past year and deeper negative total returns over the past 3 and 5 years, which may catch the eye of value focused investors. See our latest analysis for Arkema. For Arkema, the...

EssilorLuxottica Société anonyme (ENXTPA:EL) is drawing attention after expanding its Ray-Ban Meta AI glasses portfolio with prescription friendly, optical first designs and broader international distribution, which links eyewear more tightly with everyday digital services. See our latest analysis for EssilorLuxottica Société anonyme. The Ray-Ban Meta news and EssilorLuxottica’s recent deal in Thailand arrive while the share price has seen a 30 day share price return of an 11.42% decline and...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

The market for Sword Group S.E.'s ( EPA:SWP ) shares didn't move much after it posted weak earnings recently. We think...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

If you are wondering whether Nanobiotix is priced attractively or already running ahead of itself, the recent share performance raises some important valuation questions. The stock last closed at €27.40, with a 3.4% gain over 7 days, a 5.0% decline over 30 days, a 44.2% return year to date, and a very large 1-year return of more than 7x. These moves have kept Nanobiotix on many investors' watchlists, supported by ongoing attention on its cancer treatment technologies and partnerships in the...

Exosens (ENXTPA:EXENS) secured a record order for its ultra compact thermal camera cores. The order comes from a major European developer of autonomous air defense systems. The thermal camera cores are intended for use in drone and counter drone applications across unmanned platforms. Exosens focuses on advanced digital imaging technologies that serve defense and security customers, with thermal imaging as a core capability. This record order reflects interest in compact, high performance...

TotalEnergies generated more than €1b in trading profits during recent Middle East supply disruptions, helped by heavy buying of UAE and Omani cargoes and risk hedging activity. The company has completed the merger of its UK North Sea business with NEO NEXT, forming NEO NEXT+ as the region’s largest independent oil and gas producer. TotalEnergies (ENXTPA:TTE) is coming off a strong share price run, with the stock at €79.42 and up 18.9% over the past month, 41.6% year to date and 58.6% over...

What Recent Returns Say About Planisware SAS Planisware SAS (ENXTPA:PLNW) has caught investor attention after a period of weak share performance, with the stock showing a 7.5% decline over the past month and a 37% decline over the past 3 months. See our latest analysis for Planisware SAS. While the recent 30 day share price return of a 7.5% decline and 90 day share price return of a 37% decline point to fading momentum, the latest €14.58 share price and 1 year total shareholder return of a...

Why Getlink stock is on investors’ radar Getlink (ENXTPA:GET) has recently drawn attention after a solid run in its shares over the past month and past 3 months, prompting investors to reassess how its core tunnel and rail operations are valued. See our latest analysis for Getlink. The recent move to a €19.37 share price comes after a 21.75% year to date share price return and a 23.03% total shareholder return over 12 months, which points to building momentum rather than a one off move. If...

L'Air Liquide (ENXTPA:AI) has attracted fresh attention after unveiling a new Advanced Materials manufacturing plant in Taichung City, Taiwan, focused on deposition and etching materials for regional semiconductor customers. See our latest analysis for L'Air Liquide. The new Taiwan facility comes at a time when the share price has shown firm momentum, with a 7 day share price return of 5.37% and a 90 day share price return of 13.53%. Meanwhile, the 5 year total shareholder return of 70.44%...

DBV Technologies plans to resubmit its Biologics License Application to the FDA for the Viaskin Peanut Patch for children after addressing earlier regulatory concerns. The resubmission follows positive Phase 3 VITESSE trial results and a strengthened financial position. Regulatory clearance for Viaskin Peanut could open a path to commercializing the patch in the pediatric peanut allergy market. For investors tracking ENXTPA:DBV, the planned BLA resubmission comes at a time when the share...